Home » Topics » Regulatory

Regulatory
RSS

Nefazodone evaluated for social phobia

July 10, 1997

Preclinical and clinical antidepressant properties of tolcapone

July 10, 1997

Promising preliminary results from open trial of lamotrigine in depression

July 9, 1997

NKH-477 possesses antidepressant effects

July 9, 1997

MGI Pharma launches INFeD for anemia in cancer patients

July 9, 1997

Immunex receives approval to market paclitaxel in Canada

July 9, 1997

Dovonex cleared for use in children in the U.K.

July 9, 1997

Losec available in U.K. for symptoms of dyspepsia

July 9, 1997

Didronel PMO now available for expanded use in the U.K.

July 9, 1997

QLT PhotoTherapeutics files for Canadian approval of lung cancer treatment

July 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....